Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: pocotrader who wrote (1306863)	7/7/2021 11:26:53 PM
From: Winfastorlose	5 Recommendations Recommended By bjzimmy FJB IC720 Maple MAGA Mick Mørmøny Read Replies (3) \| Respond to of 1571785

Now that you found out the vaccines are useless in stopping the spread of the marauding, dreaded Delta, are you going back into full mask lockdown mode for the duration of your life? Vaccine stocks Moderna ( MRNA), BioNTech ( BNTX) and Novavax ( NVAX) skidded Wednesday as the highly contagious Delta variant became the most prevalent Covid strain in the U.S. Investors Business Daily

To: pocotrader who wrote (1306863)	7/8/2021 1:28:44 AM
From: Winfastorlose	1 Recommendation Recommended By Mick Mørmøny Read Replies (1) \| Respond to of 1571785

Just when you thought it was safe to go into the water....Da dum, da dum, da dum.. Along comes Lambda! The most aggressive variant ever! Now we have Alpha, Beta, Gamma, Delta and Lambda. Get a few more and we can house them all on UCLA's Fraternity Row and shoot a new movie. Animal House 2. Which house would you like to pledge? Beta, Delta or Lambda? A new fast-spreading COVID-19 variant called Lambda has left scientists puzzled due to its ‘unusual set of mutations’. pic.twitter.com/95rtMMZrev — Husserl (@husserl80) July 5, 2021

To: pocotrader who wrote (1306863)	7/8/2021 1:47:36 AM
From: Winfastorlose	1 Recommendation Recommended By Mick Mørmøny Read Replies (1) \| Respond to of 1571785

From the inventor of mRNA therapies: Dr. Robert Malone Dr. Robert Malone, mRNA Vaccine Inventor, on the Bioethics of Experimental Vaccines and the ‘Ultimate Gaslighting’ I think the data keeps getting stronger and stronger in favor of ivermectin as having some protective activity within a safe dosing range. And that seems to be impacting in various emerging economies that don’t have access to vaccines and is impacting on event rate for severe COVID disease and death. So there’s some great kind of epidemiologic studies or data coming out of India where Indian States had been on ivermectin. The incidents of attack rate of disease was low. Then they withdrew it for political reasons. There was a change in regime. It went up. Then they reimplemented it. It went back down again. So that’s pretty strong evidence. There is also reasonable evidence for the use of ivermectin as a therapeutic, but there are many others. And it’s just the one that has gotten a lot of press, in part because of Pierre Kory, Senate testimony. And so ivermectin, even a whole host of anti-inflammatories, because what folks often don’t understand about COVID is that we have the SARS-CoV-2 virus infection event. And typically, that leads to a disease of varying severity at something in the range of four to seven or eight days afterwards. But that disease only happens in a subset of patients, maybe 80%, maybe 50% of patients taken across all age groups, maybe even less. And the disease is the hyperinflammatory response to the virus. So the disease is really our reaction to the virus. The good news is with drugs is that we have this rich library of anti-inflammatory drugs that appear to be quite useful against keeping people out of the hospital if it’s used early enough or treating them once they’re in the hospital. The antiviral that’s been licensed, remdesivir, in the United States, the WHO is not recommending remdesivir globally, and many physicians in the United States find remdesivir to be of limited use in special situations. So the idea of antivirals for this is really not panning out. And there are multiple other antivirals that have been tested. This is often the case with respiratory viruses. theepochtimes.com